Chronic News and Research

RSS

ARIAD provides update on corporate developments, reports Q1 2014 financial results

ARIAD Pharmaceuticals, Inc. today reported financial results for the first quarter of 2014, including revenue from sales of Iclusig® (ponatinib) and licensing agreements. The Company also provided an update on corporate developments.

7 May 2014

Humana reports EPS of $2.35 in Q1 2014; confirms EPS guidance for FY14

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2014 (1Q14) of $2.35, compared to diluted earnings per common share (EPS) of $2.95 for the quarter ended March 31, 2013 (1Q13).

7 May 2014

Research on how heart rate increases in response to alertness in brain

George Washington University (GW) researcher David Mendelowitz, Ph.D., was recently published in the Journal of Neuroscience for his research on how heart rate increases in response to alertness in the brain.

7 May 2014

New project aims to find better weapons against life-threating multi-resistant bacteria

A Norwegian-Danish project aims to find better weapons against life-threating multi-resistant bacteria.

7 May 2014

RPCI research finds patients with metastatic kidney cancer benefit from HDIL-2 immunotherapy

A retrospective study published online ahead of print in the medical journal Urology by a physician team from Roswell Park Cancer Institute (RPCI) found that patients with metastatic kidney cancer — even those with chronic renal insufficiency — can tolerate and benefit from a treatment called high-dose interleukin-2 (HDIL-2) immunotherapy.

7 May 2014

New research focuses on using wheat fiber to lower cholesterol and prevent development of heart disease

The saying, "we are what we eat," has never been more true. Nutritionists increasingly emphasize that the nutrients in the foods we consume can potentially create health and reduce disease.

7 May 2014

Researchers discover genetic risk factor for premature birth

Researchers at the University of California, San Diego School of Medicine have discovered a genetic risk factor for premature birth.

7 May 2014

Protein molecule seems to slow progression of deadly lung disease

Researchers at the University of Illinois at Chicago College of Medicine have discovered a protein molecule that seems to slow the progression of pulmonary fibrosis, a progressive lung disease that is often fatal three to five years after diagnosis.

7 May 2014

Inflammatory pneumococcal response differs by age

The composition of inflammatory lung infiltrate in people with pneumonia caused by Streptococcus pneumoniae differs by age, an in-situ study reveals.

6 May 2014

Global risk assessment urged for hypertensive patients

Global risk assessment has a large impact on the risk stratification and therefore management of patients with hypertension, a study shows.

6 May 2014

Bayer to purchase consumer care business of Merck & Co, signs co-development deal for sGC modulators

Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA, for a purchase price of USD 14.2 billion (EUR 10.4 billion).

6 May 2014

Viewpoints: Battle for Medicaid; GOP's report on enrollment off base; need for kidney donations

The final battle of the war over the Affordable Care Act is being waged today over expanding Medicaid. ... The refusal of more than half the states to cover so many of their neediest citizens - the number who have fallen into the "coverage gap" is estimated at 5 million - amazes and frustrates health experts.

6 May 2014

Highlights: High Colo. insurance rate changes; La. hospital plan rejected; VA delays in care

A selection of health policy stories from Colorado, Louisiana, Arizona, California, Florida and Michigan.

6 May 2014

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Tufts University today announced that it has licensed a novel silk technology for the treatment of chronic skin wounds to Akeso Biomedical, Inc., an early stage medical device company.

6 May 2014

Teva's SYNRIBO for injection receives FDA approval for home administration

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved SYNRIBO® (omacetaxine mepesuccinate) for injection, for subcutaneous use, to include home administration, and also approved a related Medication Guide and Instructions for Use.

6 May 2014

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental Biologics License Application (sBLA) providing regular approval for Soliris® (eculizumab) for the treatment of adult and pediatric patients with atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA).

6 May 2014

Being obese at age 25 places individuals at risk of severe level of obesity later in life

Exposure to long-term obesity has become more common with increases in obesity at younger ages. Researchers examined the relationship between BMI at age 25, obesity later in life, and biological indicators of health.

6 May 2014

Women who experience physical violence by partner are more likely to be smokers

One third of women around the world have experienced physical or sexual violence at the hands of their intimate partners with consequences from post-traumatic stress disorder, anxiety, and depression, to sexually transmitted diseases, including HIV.

6 May 2014

NCCN publishes new patient resource for stage 0 breast cancer

The National Comprehensive Cancer Network (NCCN), with the support of the NCCN Foundation®, announces the availability of the NCCN Guidelines for Patients: Breast Cancer Stages 0 - IV—the latest addition to the library of NCCN Guidelines for Patients available online free-of-charge at NCCN.org/patients.

6 May 2014

Phosphate linked to cause high blood pressure and heart disease

Researchers find link between phosphate rich foods and an enzyme linked to cardiovascular disease. The findings also link phosphates to renal disease.

6 May 2014

Chronic News and Research

ARIAD provides update on corporate developments, reports Q1 2014 financial results

Humana reports EPS of $2.35 in Q1 2014; confirms EPS guidance for FY14

Research on how heart rate increases in response to alertness in brain

New project aims to find better weapons against life-threating multi-resistant bacteria

RPCI research finds patients with metastatic kidney cancer benefit from HDIL-2 immunotherapy

New research focuses on using wheat fiber to lower cholesterol and prevent development of heart disease

Researchers discover genetic risk factor for premature birth

Protein molecule seems to slow progression of deadly lung disease

Inflammatory pneumococcal response differs by age

Global risk assessment urged for hypertensive patients

Bayer to purchase consumer care business of Merck & Co, signs co-development deal for sGC modulators

Viewpoints: Battle for Medicaid; GOP's report on enrollment off base; need for kidney donations

Highlights: High Colo. insurance rate changes; La. hospital plan rejected; VA delays in care

Tufts licenses novel silk technology for treatment of chronic skin wounds to Akeso Biomedical

Teva's SYNRIBO for injection receives FDA approval for home administration

FDA approves Alexion’s Soliris drug for treatment of atypical hemolytic uremic syndrome

Being obese at age 25 places individuals at risk of severe level of obesity later in life

Women who experience physical violence by partner are more likely to be smokers

NCCN publishes new patient resource for stage 0 breast cancer

Phosphate linked to cause high blood pressure and heart disease

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News